跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 101 条关于
“transaminase”
全部
101
临床试验
20
药物
4
机构
0
资讯
77
去年
FDA Issues Black Box Warning for Fezolinetant (Veozah) Due to Liver Injury Risk
去年
Omaveloxolone Shows Sustained Safety and Efficacy in Friedreich Ataxia Treatment
去年
Sarepta Therapeutics Shares Drop 10% Following New Liver Injury Report for Gene Therapy Elevidys
去年
Third Harmonic Bio's THB335 Shows Promising Phase 1 Results for Chronic Urticaria Treatment
2年前
FDA Approves Eflornithine for High-Risk Neuroblastoma to Reduce Relapse Risk
去年
Elafibranor Demonstrates Improved Transplant-Free Survival in PBC Patients
去年
BioAge Labs Shifts Focus to NLRP3 Inhibitor After Azelaprag Trial Discontinued
去年
Semaglutide 2.4 mg Shows Promise in MASH Treatment: Phase 3 ESSENCE Trial Results
6个月前
NorthSea Therapeutics Secures Orphan Drug Designations for Orziloben in Rare Liver Disease
去年
MetaVia's DA-1241 Shows Positive Phase 2a Results in MASH Patients
第 1 页,共 8 页
上一页
下一页